Li Feixue, Curry Thomas E
Department of Obstetrics and Gynecology, Chandler Medical Center, University of Kentucky, Lexington, Kentucky 40536-0298, USA.
Endocrinology. 2009 Aug;150(8):3903-12. doi: 10.1210/en.2008-1141. Epub 2009 Apr 23.
In the ovary, the matrix metalloproteinases (MMPs) and the tissue inhibitors of metalloproteinase (TIMPs) have been postulated to regulate extracellular matrix remodeling associated with ovulation. In the present study, we investigated the regulatory mechanisms controlling expression of Timp1 and Timp3 mRNA in periovulatory granulosa cells. Granulosa cells were isolated from immature pregnant mare serum gonadotropin-primed (10 IU) rat ovaries and treated with human chorionic gonadotropin (hCG; 1 IU/ml). At 4 h after hCG treatment, Timp1 expression was highest and then decreased gradually over the remaining 24 h of culture. In contrast, hCG induced a biphasic increase of Timp3 expression at 2 and 16 h. The hCG stimulated expression of Timp1 and Timp3 mRNA was blocked by inhibitors of the protein kinase A (H89), protein kinase C (GF109203), and MAPK (SB2035850) pathways. To further explore Timp1 and Timp3 regulation, cells were cultured with the progesterone receptor antagonist RU486, which blocked the hCG induction of Timp3 expression, whereas the epidermal growth factor receptor tyrosine kinase inhibitor AG1478 blocked the hCG stimulation of both Timp1 and Timp3 expression. The prostaglandin-endoperoxide synthase 2 inhibitor NS-398 had no effect. The potential function of TIMP3 was investigated with Timp3-specific small interfering RNA treatment. Timp3 small interfering RNA resulted in a 20% decrease in hCG-induced progesterone levels and microarray analysis revealed an increase in cytochrome P450 Cyp 17, ubiquitin conjugating enzyme E2T, and heat shock protein 70. IGF binding protein 5, stearyl-CoA desaturase, and annexin A1 were decreased. The differential regulation between Timp1 and Timp3 may correlate with their unique roles in the processes of ovulation and luteinization. For TIMP3, this may include regulating fatty acid synthesis, steroidogenesis, and protein turnover.
在卵巢中,基质金属蛋白酶(MMPs)和金属蛋白酶组织抑制剂(TIMPs)被认为可调节与排卵相关的细胞外基质重塑。在本研究中,我们调查了控制排卵周围颗粒细胞中Timp1和Timp3 mRNA表达的调控机制。从用孕马血清促性腺激素(10 IU)预处理的未成熟大鼠卵巢中分离颗粒细胞,并用人类绒毛膜促性腺激素(hCG;1 IU/ml)处理。hCG处理后4小时,Timp1表达最高,然后在培养的剩余24小时内逐渐下降。相比之下,hCG诱导Timp3表达在2小时和16小时出现双相增加。hCG刺激的Timp1和Timp3 mRNA表达被蛋白激酶A(H89)、蛋白激酶C(GF109203)和丝裂原活化蛋白激酶(SB2035850)途径的抑制剂阻断。为了进一步探索Timp1和Timp3的调控,细胞用孕激素受体拮抗剂RU486培养,其阻断了hCG对Timp3表达的诱导,而表皮生长因子受体酪氨酸激酶抑制剂AG1478阻断了hCG对Timp1和Timp3表达的刺激。前列腺素内过氧化物合酶2抑制剂NS-398没有作用。用Timp3特异性小干扰RNA处理研究了TIMP3的潜在功能。Timp3小干扰RNA导致hCG诱导的孕酮水平降低20%,微阵列分析显示细胞色素P450 Cyp 17、泛素结合酶E2T和热休克蛋白70增加。胰岛素样生长因子结合蛋白5、硬脂酰辅酶A去饱和酶和膜联蛋白A1减少。Timp1和Timp3之间的差异调节可能与其在排卵和黄体化过程中的独特作用相关。对于TIMP3,这可能包括调节脂肪酸合成、类固醇生成和蛋白质周转。